V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330010414 | 330008692 | 1.69 | null | Palliative (P) | 2015-03-30 | 2015-08-25 | EW Rel rEECur Irinotecan/Temozolomide | N | N | 330014951 | IRINOTECAN + TEMOZOLOMIDE |
| 330010415 | 330004925 | 1.7 | 102 | Disease modification (D) | 2015-07-04 | 2015-07-10 | CISPLATIN + ETOPOSIDE | N | N | 330014953 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330010418 | 330008696 | 0 | 5.4 | Palliative (P) | 2015-12-09 | 2015-12-09 | Temozolomide 150mg/m2 | 01 | Y | 330015068 | TEMOZOLOMIDE |
| 330010419 | 330004937 | 1.65 | null | Curative (C) | 2016-07-09 | 2016-08-10 | EW EuroEwing 99 : VActI | Y | N | 330015103 | EURO-EWING |
| 330010420 | 330008698 | 1.83 | 74.2 | Palliative (P) | 2014-08-13 | 2015-05-27 | EURO-EWING | 02 | N | 330015114 | EURO-EWING |
| 330010421 | 330008699 | 1.5 | 58.5 | Palliative (P) | 2014-04-19 | 2014-04-20 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330015115 | DA |
| 330010422 | 330004942 | null | 78.8 | Palliative (P) | 2014-03-15 | 2014-06-07 | Etoposide oral | 02 | N | 330015116 | ETOPOSIDE |
| 330010423 | 330004946 | 1.8 | null | Adjuvant (A) | null | 2017-10-02 | Cisplatin + Doxorubicin | null | null | 330015123 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330010424 | 330004947 | null | 88 | Palliative (P) | 2015-03-29 | 2015-03-29 | Etoposide oral | N | N | 330015123 | ETOPOSIDE |
| 330010425 | 330004950 | 1.63 | 81.2 | Curative (C) | 2013-08-17 | 2013-08-18 | FLAG + Idarubicin | 02 | N | 330015137 | FLAG + IDARUBICIN |
| 330010426 | 330008703 | 1.81 | 77.1 | Palliative (P) | 2014-08-24 | 2014-10-06 | Cyclophosphamide + Topotecan | N | null | 330015173 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330010427 | 330010719 | null | 13.2 | Neo-adjuvant (N) | 2016-03-29 | 2016-09-24 | DA 3+8 | N | N | 330015176 | VINBLASTINE |
| 330010428 | 330004956 | 1.66 | 45.2 | Palliative (P) | 2016-02-17 | 2016-02-19 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330015177 | LIPOSOMAL DOXORUBICIN |
| 330010429 | 330008707 | 1.6 | 0 | Palliative (P) | 2016-02-19 | 2016-02-20 | Trabectedin | 02 | N | 330015185 | TRABECTEDIN |
| 330010430 | 330008708 | 1.63 | 11.5 | Palliative (P) | 2014-06-07 | 2014-06-11 | Irinotecan + Temozolomide | N | N | 330015195 | IRINOTECAN + TEMOZOLOMIDE |
| 330010432 | 330004968 | 1.67 | 63.5 | Curative (C) | 2016-10-28 | 2016-10-29 | AML Int Guide HD Cytarabine (3 + 4) | 02 | N | 330015244 | CYTARABINE HIGH DOSE |
| 330010433 | 330004969 | 0 | 61.7 | Curative (C) | null | 2018-05-11 | Cytarabine High Dose | 02 | N | 330015244 | CYTARABINE HIGH DOSE |
| 330010434 | 330004971 | 1.72 | 14.35 | Curative (C) | 2014-08-02 | 2014-08-02 | Cyclophosphamide + Dex + Rituximab | 02 | N | 330015329 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330010435 | 330004971 | 1.77 | 11.8 | Curative (C) | 2014-08-24 | 2014-09-06 | Cyclophosphamide + Dex + Rituximab | 2 | N | 330015329 | VINBLASTINE |
| 330010436 | 330004972 | 1.89 | null | null | null | 2017-02-23 | FLAG + Idarubicin | N | null | 330015345 | FLAG + IDARUBICIN |
| 330010438 | 330004975 | 1.75 | 68.4 | Palliative (P) | 2017-09-02 | 2017-09-02 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330015414 | LIPOSOMAL DOXORUBICIN |
| 330010439 | 330008716 | 1.85 | 77.3 | Palliative (P) | 2018-01-06 | 2018-01-07 | GemCarbo Days 1+8 | N | null | 330015415 | GEMCARBO |
| 330010440 | 330008716 | 1.7 | null | null | 2015-02-21 | 2015-07-19 | VAC | N | N | 330015415 | DA |
| 330010441 | 330004978 | 1.78 | 89.5 | Adjuvant (A) | 2018-09-24 | 2018-10-09 | Azacitidine | N | N | 330015430 | VINBLASTINE |
| 330010442 | 330004979 | null | 66.6 | Curative (C) | 2015-06-02 | 2015-06-02 | Cytarabine High Dose | null | null | 330015477 | CYTARABINE HIGH DOSE |
| 330010443 | 330004983 | 1.65 | 8.4 | Curative (C) | 2013-08-03 | 2013-08-03 | NIVOLUMAB | N | N | 330015523 | CISPLATIN + DOXORUBICIN |
| 330010444 | 330004985 | 1.81 | null | Palliative (P) | 2016-08-27 | 2017-05-22 | VAC | N | N | 330015541 | TEMOZOLOMIDE |
| 330010445 | 330004986 | 0 | 102 | Curative (C) | 2014-10-24 | 2016-08-28 | NIVOLUMAB | N | N | 330015562 | VINBLASTINE |
| 330010446 | 330004988 | 1.6 | 69.8 | Curative (C) | 2017-03-18 | 2017-03-28 | TEMOZOLOMIDE | N | N | 330015593 | NIVOLUMAB |
| 330010447 | 330010730 | 1.77 | 62.3 | Disease modification (D) | 2015-05-20 | 2015-06-11 | Cisplatin + Doxorubicin | N | N | 330015595 | AZACITIDINE |
| 330010448 | 330004992 | 1.53 | 94.7 | Palliative (P) | 2017-10-13 | 2017-10-13 | FLAG + Idarubicin | N | N | 330015651 | FLAG + IDARUBICIN |
| 330010449 | 330004994 | 1.31 | 59 | Palliative (P) | 2015-09-06 | 2015-10-01 | Liposomal Doxorubicin (Caelyx) | N | null | 330015657 | LIPOSOMAL DOXORUBICIN |
| 330010450 | 330004996 | 1.72 | 92.1 | Disease modification (D) | 2018-09-02 | 2018-09-04 | Trabectedin | 2 | N | 330015668 | TRABECTEDIN |
| 330010451 | 330004996 | 1.83 | 71 | Neo-adjuvant (N) | 2018-04-21 | 2018-04-21 | LIPOSOMAL DOXORUBICIN | 2 | N | 330015668 | LIPOSOMAL DOXORUBICIN |
| 330010452 | 330004997 | 1.7 | 64 | Palliative (P) | 2016-11-02 | 2017-04-04 | Cyclophosphamide + Topotecan | N | N | 330015679 | DA |
| 330010453 | 330005000 | 1.78 | 15.3 | Palliative (P) | 2014-04-11 | 2014-04-11 | Etoposide oral | N | N | 330015714 | ETOPOSIDE |
| 330010454 | 330005002 | 1.81 | 65.5 | Palliative (P) | 2017-12-04 | 2017-12-05 | ETOPOSIDE | N | N | 330015757 | ETOPOSIDE |
| 330010455 | 330010735 | 1.7 | null | Adjuvant (A) | 2013-06-23 | 2013-07-15 | CAV | N | N | 330015800 | VINBLASTINE |
| 330010456 | 330012481 | null | null | Palliative (P) | 2015-08-04 | 2016-02-15 | Azacitidine | N | N | 330015829 | VINBLASTINE |
| 330010457 | 330008733 | 1.68 | 63.5 | Curative (C) | 2014-10-30 | 2015-03-23 | EW EuroEwing 99 : VIDE | N | N | 330015848 | EURO-EWING |
| 330010458 | 330010737 | 1.59 | 52 | Palliative (P) | 2016-01-05 | 2016-01-05 | Cisplatin + Doxorubicin | N | N | 330015869 | NIVOLUMAB |
| 330010459 | 330010737 | 1.77 | 70 | Palliative (P) | null | 2019-06-09 | FLAG + Idarubicin | 02 | null | 330015869 | FLAG + IDARUBICIN |
| 330010460 | 330008737 | 1.75 | 74.9 | Palliative (P) | 2012-06-14 | 2013-03-25 | TEMOZOLOMIDE | N | N | 330015927 | CAV |
| 330010461 | 330010739 | 1.67 | 72.4 | Palliative (P) | 2013-11-03 | 2013-11-13 | Vinblastine | 02 | N | 330015927 | CISPLATIN + DOXORUBICIN |
| 330010462 | 330005013 | null | 53.6 | Not known (9) | 2017-04-07 | 2017-07-30 | Liposomal Doxorubicin (Caelyx) | N | N | 330015964 | LIPOSOMAL DOXORUBICIN |
| 330010463 | 330005014 | 1.72 | 104.6 | Palliative (P) | 2014-05-08 | 2014-10-08 | Etoposide oral | N | N | 330015969 | ETOPOSIDE |
| 330010464 | 330005017 | 1.64 | 69.6 | Curative (C) | 2013-09-25 | 2013-09-30 | CISPLATIN + ETOPOSIDE | N | N | 330015971 | DA |
| 330010465 | 330005020 | 1.78 | 112 | Curative (C) | 2013-05-15 | 2013-05-30 | Methotrexate intrathecal | N | N | 330015996 | METHOTREXATE INTRATHECAL |
| 330010466 | 330005026 | 1.79 | 121.75 | Curative (C) | 2014-08-01 | 2014-08-02 | EW EuroEwing 99 : VIDE | 02 | N | 330016047 | EURO-EWING |
| 330010467 | 330005028 | 1.74 | null | Curative (C) | 2013-07-21 | 2013-11-03 | CNS Low Grade Glioma Vinblastine | null | null | 330016049 | VINBLASTINE |